Santiago Vilar
Orcid: 0000-0003-2663-4370
According to our database1,
Santiago Vilar
authored at least 16 papers
between 2002 and 2018.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
Online presence:
-
on orcid.org
On csauthors.net:
Bibliography
2018
Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media.
Briefings Bioinform., 2018
2017
The role of drug profiles as similarity metrics: applications to repurposing, adverse effects detection and drug-drug interactions.
Briefings Bioinform., 2017
2016
Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associations.
J. Cheminformatics, 2016
2015
Toward a complete dataset of drug-drug interaction information from publicly available sources.
J. Biomed. Informatics, 2015
2014
A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records.
J. Am. Medical Informatics Assoc., 2014
Proceedings of the AMIA 2014, 2014
2013
Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions.
J. Am. Medical Informatics Assoc., 2013
2012
<i>In Silico</i> screening for agonists and blockers of the β<sub>2</sub> adrenergic receptor: Implications of inactive and activated state structures.
J. Comput. Chem., 2012
J. Am. Medical Informatics Assoc., 2012
2011
Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.
J. Am. Medical Informatics Assoc., 2011
Proceedings of the Towards an Information Theory of Complex Networks, 2011
2010
Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta<sub>2</sub>-adrenergic receptor.
J. Comput. Chem., 2010
2008
QSAR model for alignment-free prediction of human breast cancer biomarkers based on electrostatic potentials of protein pseudofolding HP-lattice networks.
J. Comput. Chem., 2008
2007
Inhibitor docking screened by the modified SAFE_p scoring function: Application to cyclic urea HIV-1 PR inhibitors.
J. Comput. Chem., 2007
2005
In Silico Studies toward the Discovery of New Anti-HIV Nucleoside Compounds through the Use of TOPS-MODE and 2D/3D Connectivity Indices. 2. Purine Derivatives.
J. Chem. Inf. Model., 2005
2002
In Silico Studies toward the Discovery of New Anti-HIV Nucleoside Compounds with the Use of TOPS-MODE and 2D/3D Connectivity Indices, 1. Pyrimidyl Derivatives.
J. Chem. Inf. Comput. Sci., 2002